These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8246138)

  • 1. Angiotensin II receptor blockade improves renal function in rats with reduced renal mass.
    Pollock DM; Divish BJ; Polakowski JS; Opgenorth TJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):657-63. PubMed ID: 8246138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan.
    Demeilliers B; Jover B; Mimran A
    J Hypertens; 1995 Dec; 13(12 Pt 2):1764-6. PubMed ID: 8903648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Losartan prevents salt-induced hypertension in reduced renal mass rats.
    Kanagy NL; Fink GD
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1131-6. PubMed ID: 8509998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system.
    Garcia R; Bonhomme MC; Diebold S
    J Hypertens; 1996 Jan; 14(1):81-9. PubMed ID: 12013499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats.
    Kohzuki M; Yasujima M; Kanazawa M; Yoshida K; Fu LP; Obara K; Saito T; Abe K
    J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
    Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
    J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of systemic and regional hemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive rats.
    Wang YX; Gavras I; Wierzba T; Gavras H
    J Lab Clin Med; 1992 Mar; 119(3):267-72. PubMed ID: 1541876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic treatment with losartan on blood pressure, endothelin-like immunoreactivity and nitric oxide in normotensive rats.
    Sacerdote A; Cosenzi A; Bocin E; Molino R; Seculin P; Plazzotta N; Luxich E; Bellini G
    J Hypertens; 1995 Dec; 13(12 Pt 2):1670-3. PubMed ID: 8903630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The advantages of angiotensin II antagonism.
    Burnier M; Waeber B; Brunner HR
    J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
    Goldberg MR; de Mey C; Wroblewski JM; Li Q; Schroeter V; Belz GG
    Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.
    Stier CT; Adler LA; Levine S; Chander PN
    J Hypertens Suppl; 1993 Apr; 11(3):S37-42. PubMed ID: 8315518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
    Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists.
    Owen RA; Molon-Noblot S; Hubert MF; Siegl PK; Eydelloth RS; Keenan KP
    Lab Invest; 1994 Oct; 71(4):543-51. PubMed ID: 7967510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
    Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V
    J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
    Burnier M; Brunner HR
    Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats.
    von Lutterotti N; Camargo MJ; Campbell WG; Mueller FB; Timmermans PB; Sealey JE; Laragh JH
    J Hypertens; 1992 Sep; 10(9):949-57. PubMed ID: 1328376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
    Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F
    Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
    Naelten G; Liu KL; Chapuis B; Lo M
    Am J Hypertens; 2005 May; 18(5 Pt 1):699-706. PubMed ID: 15882554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.